Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/28406
EVALUATION OF M. TUBERCULOSIS-INDUCED RESPONSE IN NEWBORNS VACCINATED WITH DIFFERENT STRAINS OF BCG
Affilliation
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
Escola de Ciências da Saúde. São Paulo, SP, Brasil
Universidade Salvador. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Estadual da Bahia. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
Escola de Ciências da Saúde. São Paulo, SP, Brasil
Universidade Salvador. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Estadual da Bahia. Salvador, BA, Brasil
Abstract
The attenuated strain of M. bovis (BCG) is established as the only available vaccine against
tuberculosis (TB), and the variance of its efficacy can range between 0 to 80% depending
on the study design, geographical areas where the study were performed, among other
aspects. Neonatal BCG vaccination can protect against severe and disseminated forms of
TB in children but in adults, justifying its use in the Brazilian vaccination schedule offered
by the Ministry of Health (MS).
Share